146 related articles for article (PubMed ID: 10704704)
1. The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer.
Chen M; Jiang GL; Fu XL; Wang LJ; Qian H; Chen GY; Zhao S; Liu TF
Lung Cancer; 2000 Apr; 28(1):11-9. PubMed ID: 10704704
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
[TBL] [Abstract][Full Text] [Related]
3. Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trial.
Fu XL; Jiang GL; Wang LJ; Qian H; Fu S; Yie M; Kong FM; Zhao S; He SQ; Liu TF
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):545-52. PubMed ID: 9336130
[TBL] [Abstract][Full Text] [Related]
4. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis.
Hazuka MB; Turrisi AT; Lutz ST; Martel MK; Ten Haken RK; Strawderman M; Borema PL; Lichter AS
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):273-84. PubMed ID: 8407401
[TBL] [Abstract][Full Text] [Related]
5. Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC.
Zhao Q; Chen G; Ye L; Shi S; Du S; Zeng Z; He J
Radiat Oncol; 2019 May; 14(1):86. PubMed ID: 31133034
[TBL] [Abstract][Full Text] [Related]
6. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.
Bradley JD; Ieumwananonthachai N; Purdy JA; Wasserman TH; Lockett MA; Graham MV; Perez CA
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):49-57. PubMed ID: 11777621
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.
Nguyen LN; Komaki R; Allen P; Schea RA; Milas L
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1053-6. PubMed ID: 10421538
[TBL] [Abstract][Full Text] [Related]
8. Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer.
Lee S; Song SY; Kim SS; Choi W; Je HU; Back GM; Cho B; Jeong SY; Choi EK
Clin Lung Cancer; 2018 Mar; 19(2):e253-e261. PubMed ID: 29196082
[TBL] [Abstract][Full Text] [Related]
9. [Assessment the efficacy of postoperative radiotherapy in the patients with non-small cell lung cancer. Retrospective study].
Chmielewska E; Jodkiewicz Z; Karwański M
Pneumonol Alergol Pol; 2012; 80(2):109-19. PubMed ID: 22370979
[TBL] [Abstract][Full Text] [Related]
10. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center.
Komaki R; Roth JA; Walsh GL; Putnam JB; Vaporciyan A; Lee JS; Fossella FV; Chasen M; Delclos ME; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):347-54. PubMed ID: 10974447
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy alone for stage I non-small cell lung cancer.
Kaskowitz L; Graham MV; Emami B; Halverson KJ; Rush C
Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):517-23. PubMed ID: 8226143
[TBL] [Abstract][Full Text] [Related]
12. Clinical radiobiology of stage T2-T3 bladder cancer.
Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
[TBL] [Abstract][Full Text] [Related]
13. Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience.
Machtay M; Seiferheld W; Komaki R; Cox JD; Sause WT; Byhardt RW
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):847-53. PubMed ID: 10386642
[TBL] [Abstract][Full Text] [Related]
14. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
[TBL] [Abstract][Full Text] [Related]
15. Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields.
Bradley JD; Wahab S; Lockett MA; Perez CA; Purdy JA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):342-7. PubMed ID: 12738307
[TBL] [Abstract][Full Text] [Related]
16. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
17. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for local control in non-small-cell lung cancer treated with definitive radiation therapy.
Chen M; Jiang GL; Fu XL; Wang LJ; Qian H; Zhao S; Liu TF
Am J Clin Oncol; 2002 Feb; 25(1):76-80. PubMed ID: 11823702
[TBL] [Abstract][Full Text] [Related]
19. Non-small cell lung cancer: prognostic factors in patients treated with surgery and postoperative radiation therapy.
Lee JH; Machtay M; Kaiser LR; Friedberg JS; Hahn SM; McKenna MG; McKenna WG
Radiology; 1999 Dec; 213(3):845-52. PubMed ID: 10580965
[TBL] [Abstract][Full Text] [Related]
20. PORTAF - postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation - study protocol for a randomized controlled trial.
Bütof R; Simon M; Löck S; Troost EGC; Appold S; Krause M; Baumann M
Trials; 2017 Dec; 18(1):608. PubMed ID: 29262836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
